Previous Close | 11.06 |
Open | 11.03 |
Bid | 11.37 x 200 |
Ask | 11.44 x 100 |
Day's Range | 10.89 - 11.42 |
52 Week Range | 9.56 - 31.46 |
Volume | |
Avg. Volume | 829,537 |
Market Cap | 810.366M |
Beta (5Y Monthly) | 1.73 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights The projected fair value for Zentalis Pharmaceuticals is US$30.67 based on 2 Stage Free Cash Flow to...
The consensus price target hints at a 136.4% upside potential for Zentalis Pharmaceuticals, Inc. (ZNTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Robust Clinical Pipeline and Strong Cash Position Highlighted in Latest Earnings Report